Advertisement
U.S. markets open in 56 minutes
  • S&P Futures

    5,307.00
    -1.25 (-0.02%)
     
  • Dow Futures

    40,158.00
    +14.00 (+0.03%)
     
  • Nasdaq Futures

    18,500.25
    -3.50 (-0.02%)
     
  • Russell 2000 Futures

    2,139.20
    +0.80 (+0.04%)
     
  • Crude Oil

    82.63
    +1.28 (+1.57%)
     
  • Gold

    2,232.40
    +19.70 (+0.89%)
     
  • Silver

    24.69
    -0.06 (-0.25%)
     
  • EUR/USD

    1.0793
    -0.0036 (-0.33%)
     
  • 10-Yr Bond

    4.1960
    0.0000 (0.00%)
     
  • Vix

    13.01
    +0.23 (+1.80%)
     
  • GBP/USD

    1.2623
    -0.0015 (-0.12%)
     
  • USD/JPY

    151.3460
    +0.1000 (+0.07%)
     
  • Bitcoin USD

    70,396.20
    +154.44 (+0.22%)
     
  • CMC Crypto 200

    885.54
    0.00 (0.00%)
     
  • FTSE 100

    7,952.37
    +20.39 (+0.26%)
     
  • Nikkei 225

    40,168.07
    -594.66 (-1.46%)
     

Clovis Oncology (CLVS) in Focus: Stock Moves 6.9% Higher

Clovis Oncology, Inc. CLVS was a big mover last session, as the company saw its shares rise nearly 7% on the day. The move came on solid volume too with far more shares changing hands than in a normal session. This continues the recent uptrend for the company as the stock is now up 46.7% in the past one-month time frame.

The company has seen six negative estimate revisions in the past few months, while its Zacks Consensus Estimate for the current quarter has also moved lower over the past few months, suggesting there may be trouble down the road. So make sure to keep an eye on this stock going forward, to see if this recent move higher can last.

Clovis Oncology currently has a Zacks Rank #3 (Hold) while its Earnings ESP is negative.  

Clovis Oncology, Inc. Price

Clovis Oncology, Inc. Price | Clovis Oncology, Inc. Quote

A better-ranked stock in the Medical - Biomedical and Genetics industry is Alexion Pharmaceuticals, Inc. ALXN, which currently carries a Zacks Rank #1 (Strong Buy). You can see the complete list of today’s Zacks #1 Rank stocks here.

Is CLVS going up? Or down? Predict to see what others think: Up or Down

Looking for Stocks with Skyrocketing Upside?

Zacks has just released a Special Report on the booming investment opportunities of legal marijuana.

Ignited by new referendums and legislation, this industry is expected to blast from an already robust $6.7 billion to $20.2 billion in 2021. Early investors stand to make a killing, but you have to be ready to act and know just where to look.

See the pot trades we're targeting>>


Want the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days. Click to get this free report
 
Alexion Pharmaceuticals, Inc. (ALXN) : Free Stock Analysis Report
 
Clovis Oncology, Inc. (CLVS) : Free Stock Analysis Report
 
To read this article on Zacks.com click here.
 
Zacks Investment Research

Advertisement